Han, X. et al. 2022. Dexmedetomidine reduces dextran sulfate sodium (DSS)-induced NCM460 cell inflammation and barrier damage by inhibiting RhoA/ROCK signaling pathway. Allergologia et Immunopathologia. 50, 3 (May 2022), 85–92. DOI:https://doi.org/10.15586/aei.v50i3.569.